Company Filing History:
Years Active: 2021
Title: François-Xavier Gendron: Innovator in Chiral Compound Resolution
Introduction
François-Xavier Gendron is a notable inventor based in Autretot, France. He has made significant contributions to the field of chemistry, particularly in the resolution of chiral compounds. His work focuses on the production of pure enantiomers, which are crucial in various pharmaceutical applications.
Latest Patents
Gendron holds a patent for a method related to the resolution of baclofen salts. The invention pertains to the production of the pure enantiomer (R)(−) Baclofen, known chemically as (R)-4-amino-3-(4-chlorophenyl)-butanoic acid, along with its hydrogen maleate salt. This method involves the resolution of hydrogen maleate salts of racemic Baclofen through preferential crystallization, specifically utilizing the AS3PC method (auto-seeded and programmed polythermal preferential crystallization). He has 1 patent to his name.
Career Highlights
Gendron is affiliated with the University of Rouen, where he has been involved in research and development in the field of chemistry. His academic background and research endeavors have positioned him as a key figure in his area of expertise.
Collaborations
Throughout his career, Gendron has collaborated with notable colleagues such as Gérard Coquerel and Julien Mahieux. These partnerships have contributed to the advancement of research in chiral compound resolution.
Conclusion
François-Xavier Gendron's innovative work in the resolution of chiral compounds highlights his importance in the field of chemistry. His contributions, particularly in the production of pure enantiomers, continue to influence pharmaceutical research and development.